SK bioscience Signs Vaccine Technology Transfer Agreement with Colombia's VECOL to Advance Local Vaccine Manufacturing in Latin America
SK bioscience collaborates with Colombia’s government-led US$260 million vaccine localization initiative through technology transfer and local manufacturing cooperation with state-owned pharmaceutical company VECOL This alliance enables SK bioscience to enter Latin America by manufacturing SKYVaricella, with potential expansion into a broader vaccine portfolio. SK–VECOL partnership establishes strategic foothold for broader LATAM expansion INCHEON, South Korea, […]




